Is Pepto-Bismol Really a Cure for Covid? New Clinical Study Seeks Answers – zoohousenews.com
- Wellness
- December 3, 2022
- No Comment
- 13
(Natural News) The University of Louisville, in partnership with Procter & Gamble (P&G), is conducting a clinical trial investigating the use of Pepto-Bismol (oral bismuth subsalicylate, or BSS) as a potential cure for the Wuhan coronavirus (Covid-19).
Researchers say that based on what is currently known about the human body’s cellular and humoral responses to pathogens, Pepto-Bismol could be a viable intervention to eliminate and prevent reinfection with enteric viral infections of which we were told will include the Fauci flu.
“Readily available over-the-counter (OTC) medications for symptomatic relief and adequate oral hydration can be health-maintaining measures of great benefit to those afflicted with enteric bacterial and viral infections,” the study description explains.
“BSS is a non-proprietary monograph product available over-the-counter (OTC) in the United States and abroad. Of all OTC drugs for travelers’ diarrhea (TD), bismuth subsalicylate (BSS) has the greatest antimicrobial activity against pathogenic bacteria. BSS has also shown significant inhibition of viral invasion of host cells and viral efficacy.”
So far, the evidence seems to indicate that BSS and bismuth oxychloride (BiOCl), which is formed in the stomach after ingestion of BSS, are highly effective in reducing levels of NoV RNA in the body. This would suggest that BSS has some kind of in vivo antiviral mechanism.
“BSS was also shown to have antiviral activity as it inhibited the replication of 4 rotavirus strains in tissue culture cells and caused a dose-dependent reduction in the growth of several enteric viruses,” the study further explains. (Related: Remember when First Lady Melania Trump claimed she used “vitamins and healthy food” to cure her own alleged Covid infection?)
Pepto-Bismol is probably safer than the jabs, but why not choose a diet instead?
Historically, BSS or Pepto-Bismol has been used effectively to treat TD and intestinal infections, particularly when symptoms involve vomiting. The claim is that it does so safely and effectively.
According to the clinical trials leaders, there is a wealth of internal industry data on BSS that further points to its effectiveness. Much of it has never been made public, and this new process is digging it all up for public scrutiny.
“Although the safety and effectiveness of BSS is known, some of the research done with BSS is within the industry and has not been published,” the study explains.
“We recently completed a comprehensive meta-analysis using unpublished clinical studies on the safety and efficacy of BSS. Meta-analyses of randomized controlled clinical trials were performed with trials specifically designed to assess prevention of onset and amelioration of diarrhea.”
As promising as this all sounds, consider that P&G owns Pepto-Bismol, meaning the company has a direct interest in promoting the drug product and declaring it safe and effective for treating the Chinese virus.
Compared to the so-called “vaccines,” Pepto-Bismol is relatively harmless, making it an option that doesn’t damage your DNA like vaccines seem to do. Still, it’s important to remember that this clinical study is not being conducted independently, which means that bias is sure to occur.
“I’ve always believed that food is medicine,” wrote a commenter at Natural News, who claims to be 80 years old, with a full head without gray hair, low blood pressure, and no aches or pains — all thanks to proper nutrition and taking care of yourself.
“The body has the ability to repair and heal itself if you give it what it needs and that is proper nutrition, sunshine, clean air and water, exercise and no chemicals. The nutrition comes from food sources and not from prescription toxic chemicals.”
To learn more about natural remedies that can help you and your family stay safe and disease-free this winter, be sure to check out Cures.news.
Sources for this article are:
ClinicalTrials.gov
zoohousenews.com